VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
CDLXCardlytics, Inc.
$5.20$30M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
  1. Home
  2. Financial Ratios

  1. Home
  2. CDLX
  3. Financial Ratios

Cardlytics, Inc. (CDLX) Financial Ratios

11 years of historical data (2015–2025) · Communication Services · Advertising Agencies

View Quarterly Ratios →

P/E Ratio
-0.27
—
5yr avg: N/A
050%ile100
View P/E History →
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
3.43
↓-51% vs avg
5yr avg: 6.93
00%ile100
30Y Low6.9·High6.9
P/B Ratio
↓
N/A
—
5yr avg: 2.26
30Y Low0.9·High24.7
ROE
↓
-326.0%
↑-126% vs avg
5yr avg: -144.4%
013%ile100
30Y Low-326%·High-18%
Debt/EBITDA
N/A
—
5yr avg: N/A

Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.

CDLX Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

Cardlytics, Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis. On a free-cash-flow basis, the stock trades at 3.4x P/FCF, 51% below the 5-year average of 6.9x.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Market Cap$30M$61M$179M$336M$193M$2.1B$3.9B$1.5B$206M——
Enterprise Value$197M$228M$335M$510M$307M$2.1B$3.8B$1.4B$214M——
P/E Ratio →-0.27——————————
P/S Ratio0.130.260.641.090.657.9720.797.091.37——
P/B Ratio——2.562.490.913.0824.7210.423.97——
P/FCF3.436.93—————3415.73———
P/OCF3.256.57—————130.28———

P/E links to full P/E history page with 30-year chart

CDLX EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
EV / Revenue—0.981.211.651.037.8320.236.601.42——
EV / EBITDA———————————
EV / EBIT———————————
EV / FCF—25.84—————3176.78———

CDLX Profitability

Margins and return-on-capital ratios measuring operating efficiency

Cardlytics, Inc. earns an operating margin of -20.2%, below the Communication Services sector average of 1.6%. Operating margins have expanded from -43.9% to -20.2% over the past 3 years, signaling improving operational efficiency. A negative ROE of -326.0% indicates the company is currently destroying shareholder equity.

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Gross Margin45.0%45.0%43.4%42.2%37.7%38.7%33.9%37.8%36.3%38.4%35.8%
Operating Margin-20.2%-20.2%-70.2%-43.9%-153.3%-45.9%-28.9%-8.2%-27.2%-13.1%-49.8%
Net Profit Margin-44.4%-44.4%-68.0%-43.6%-155.8%-48.1%-29.7%-8.1%-35.2%-15.1%-67.1%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
ROE-326.0%-326.0%-184.9%-77.8%-103.1%-30.3%-36.9%-17.6%-102.1%——
ROA-30.5%-30.5%-39.2%-21.3%-47.6%-15.2%-17.1%-9.1%-41.7%-20.9%-89.5%
ROIC-18.3%-18.3%-54.8%-32.1%-70.1%-26.0%-89.0%-26.5%———
ROCE-20.9%-20.9%-60.5%-32.1%-66.4%-19.2%-22.1%-14.0%-51.0%-32.3%-180.6%

CDLX Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

Net debt stands at $167M ($215M total debt minus $49M cash).

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Debt / Equity——3.171.971.110.291.200.000.90——
Debt / EBITDA———————————
Net Debt / Equity——2.231.290.54-0.05-0.67-0.730.14——
Net Debt / EBITDA———————————
Debt / FCF—18.91—————-238.95———
Interest Coverage-8.74-8.74-20.26-20.79-116.21-9.63-15.02-12.05-15.25-1.37-4.92

CDLX Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

A current ratio of 1.75x means Cardlytics, Inc. can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has improved from 1.31x to 1.75x over the past 3 years.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Current Ratio1.751.751.191.311.001.104.742.502.401.771.73
Quick Ratio1.751.751.191.311.001.104.742.502.011.771.72
Cash Ratio0.620.620.440.540.490.713.611.330.760.500.58
Asset Turnover—0.820.710.540.430.210.440.940.981.291.30
Inventory Turnover————————4.74—557.02
Days Sales Outstanding—133.40140.40148.74146.81160.12169.04148.06146.65143.48141.75

CDLX Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Cardlytics, Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Dividend Yield———————————
Payout Ratio———————————

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Earnings Yield———————————
FCF Yield29.2%14.4%—————0.0%———
Buyback Yield0.0%0.0%0.0%0.0%20.7%0.0%0.0%0.0%0.0%——
Total Shareholder Yield0.0%0.0%0.0%0.0%20.7%0.0%0.0%0.0%0.0%——
Shares Outstanding—$5M$5M$4M$3M$3M$3M$2M$2M$2M$1M

Peer Comparison

Compare CDLX with 10 similar companies in its peer group

CompanyMarket CapP/EEV/EBITDAP/FCFGross MarginOp MarginROEROICDebt/EBITDA
CDLX logoCDLXYou$30M-0.3—3.445.0%-20.2%-326.0%-18.3%—
PERI logoPERI$351M-44.873.99.230.5%-3.1%-1.1%-1.7%10.3
MGNI logoMGNI$3B18.815.115.562.7%13.7%17.1%9.5%1.8
APPS logoAPPS$1B-26.1—92.948.6%6.0%-21.8%4.8%—
ACMR logoACMR$7B80.254.2—44.4%12.1%6.2%7.0%2.4
IAS logoIAS$2B45.013.722.478.5%11.4%3.9%4.6%0.5
TTD logoTTD$9B20.312.010.978.6%20.3%16.3%21.3%0.6
CRTO logoCRTO$876M6.62.14.254.0%10.4%12.8%16.1%0.5
PUBM logoPUBM$528M-36.516.17.963.6%-6.1%-5.4%-6.8%1.7
DV logoDV$2B34.410.59.282.2%10.6%4.6%6.4%0.7
KLAR logoKLAR$7B-23.8——35.3%-6.5%-11.9%-760.0%—
Communication Services Median—15.39.611.448.5%1.6%2.0%2.6%3.6

Peer selection based on competitive and market overlap. Compare multiple stocks →

Download Financial Ratios Data

Includes 30+ ratios · 11 years · Updated daily

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

CDLX — Frequently Asked Questions

Quick answers to the most common questions about buying CDLX stock.

What is Cardlytics, Inc.'s P/E ratio?

Cardlytics, Inc.'s current P/E ratio is -0.3x. This places it at the 50th percentile of its historical range.

What is Cardlytics, Inc.'s ROE?

Cardlytics, Inc.'s return on equity (ROE) is -326.0%. The historical average is -109.8%.

Is CDLX stock overvalued?

Based on historical data, Cardlytics, Inc. is trading at a P/E of -0.3x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.

What are Cardlytics, Inc.'s profit margins?

Cardlytics, Inc. has 45.0% gross margin and -20.2% operating margin.